drugset / Trial / NCT05258123

Ginkgo Biloba Extract in the Treatment of Schizophrenia

NCT05258123

Completed 100 enrolled Beijing HuiLongGuan Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

We investigated the effects of Ginkgo biloba extract on the symptoms and cognitive functioning in patients with schizophrenia

Timeline

Start
2017-05-15
Primary completion
2018-06-12
Completion
2018-08-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 360 mg

Indications